George Dailey
Endocrinology, Diabetes & Metabolism · la Jolla, CANPI 1841266343
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,767 of the $22,631 with a category attached, or 82.9%. 25 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 48.6% of the total. Reporting peaked in 2019 at $14,611 and has fallen 99.9% since, to $21 in 2022.
Across 146 payments — averaging $155.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$11K
- Boehringer Ingelheim$10K
- AstraZeneca$502
- AbbVie$172
- Insulet Corporation$137
- Lilly USA, LLC$135
- plus $859 from 19 others
Across 29 payments — averaging $3095.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$87K
- Sanofi-aventis U.S. LLC$2K
- Lexicon Pharmaceuticals, Inc.$579
What the payments were for
- Speaking & faculty fees$18,76783%
- Travel & lodging$1,1995%
- Food & beverage$2,65112%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 32 | $11,000 |
| Boehringer Ingelheim | 11 | $9,827 |
| AstraZeneca(2 entities) | 25 | $502 |
| AbbVie(2 entities) | 11 | $172 |
| Insulet Corporation | 8 | $137 |
| Lilly USA, LLC | 16 | $135 |
| Eli Lilly | 2 | $96 |
| Amgen(2 entities) | 4 | $87 |
| Tandem Diabetes Care, Inc. | 2 | $82 |
| Antares Pharma, Inc. | 5 | $77 |
| Corcept Therapeutics | 4 | $76 |
| Abbott | 2 | $60 |
| Sunovion Pharmaceuticals Inc. | 4 | $56 |
| Mannkind Corporation | 3 | $42 |
| Philips North America LLC | 2 | $41 |
| Insmed, Inc. | 2 | $39 |
| Johnson & Johnson | 3 | $36 |
| Dexcom, Inc. | 2 | $28 |
| Merck | 2 | $25 |
| United Therapeutics Corporation | 1 | $21 |
| Radius Health, Inc. | 1 | $21 |
| Senseonics, Incorporated | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Electromed, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$9,698
- SOLIQUA 100/33$8,097
- TOUJEO$2,488
- FARXIGA$125
How this compares
$22,631 in reported general payments places this provider in the 85th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in la Jolla
- Daniel Einhornla Jolla$578K
- Athena Philis-Tsimikasla Jolla$574K
- Matthew Levinela Jolla$134K
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.